CVS Health Faces 340B Headwinds, Larger Earnings Risks in 2027, BofA Says
MT newswire2026/10/06 15:2611:26 AM EDT, 10/06/2026 (MT Newswires) -- CVS Health (CVS) faces manageable 340B headwinds in 2026, with larger earnings risks emerging in 2027, BofA Securities said in a Tuesday note. Analysts estimate total earnings per share risk of about $0.45, with $0.06 of headwinds impacting the business in 2026 and larger risks in 2027. BofA said headwinds include a growing list of drugmakers requiring claim-level data to approve 340B discounts, a proposed rule that would reduce 340B reimbursement, and lawsuits from a few covered entities alleging CVS is retaining excess 340B spreads. The proposed reimbursement change could result in a $600 million to $700 million EBIT headwind in 2027, according to the note. Analysts added, however, that the company has multiple ways to offset these headwinds, including through Aetna margin recovery, continued specialty pharmacy growth, and biosimilar adoption. BofA reiterated a buy rating on the stock and cut its price objective to $110 from $120. Price: 85.83, Change: -1.18, Percent Change: -1.36
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
